VTRO (Vitro Biopharma) Total Equity: $2.84 Mil (As of Oct. 2022)


What is Vitro Biopharma Total Equity?

Vitro Biopharma VTRO Total Equity is $2.84 Mil as of Oct. 2022. The stock has 6 warning signs investors should review.

Vitro Biopharma's total equity for the quarter that ended in Oct. 2022 was $2.84 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Vitro Biopharma Total Equity Historical Data

* Premium members only.

The historical data trend for Vitro Biopharma's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vitro Biopharma Total Equity Chart

Vitro Biopharma Annual Data
Trend Oct09 Oct10 Oct11 Oct12 Oct13 Oct14 Oct15 Oct17 Oct21 Oct22
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.16 -2.38 -3.03 3.46 2.84

Vitro Biopharma Quarterly Data
Oct00 Oct01 Oct02 Oct03 Oct04 Oct05 Oct06 Oct07 Oct08 Oct09 Oct10 Oct11 Oct12 Oct13 Oct14 Oct15 Oct17 Oct21 Oct22
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.16 -2.38 -3.03 3.46 2.84

Vitro Biopharma Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Vitro Biopharma's Total Equity for the fiscal year that ended in Oct. 2022 is calculated as

Total Equity=Total Assets(Q: Oct. 2022 )-Total Liabilities(Q: Oct. 2022 )
=8.574-5.738
=2.84

Vitro Biopharma's Total Equity for the quarter that ended in Oct. 2022 is calculated as

Total Equity=Total Assets(Q: Oct. 2022 )-Total Liabilities(Q: Oct. 2022 )
=8.574-5.738
=2.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $2.84 Mil mean?
Vitro Biopharma (VTRO) has a Total Equity of $2.84 Mil as of Oct. 2022. The total amount of equity as record on a company's balance sheet. View historical data for Vitro Biopharma and its competitors.
Is Vitro Biopharma's Total Equity too high?
Vitro Biopharma's current Total Equity is $2.84 Mil.
How does Vitro Biopharma's Total Equity compare to ?
Vitro Biopharma's Total Equity of $2.84 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Vitro Biopharma and its competitors. Vitro Biopharma's current Total Equity is $2.84 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vitro Biopharma stock overvalued right now?
Vitro Biopharma (VTRO) has a current Total Equity of $2.84 Mil. The current Total Equity is $2.84 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Vitro Biopharma (VTRO), the current Total Equity is $2.84 Mil as of Oct. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vitro Biopharma Business Description

Comparable Companies
Address 4621 Technology Drive, Golden, CO, USA, 80403
Vitro Diagnostics Inc is a US-based company, which is dedicated to providing high-quality commercialized cell lines, media, and stem cell technology for applications in stem cell research, drug discovery, and therapies. In addition, it also provides tools for clinical development focused on Mesenchymal Stem Cells (MSCs). Further, it offers cancer-associated fibroblasts (CAFs), which are used in the discovery of a new type of CAFs present in pancreatic cancer tumors, called pancreatic stellate cells. Geographically business activities are functioned through the region of United States.